Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | ABL1 | P00519 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | IDE | P14735 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | HLCS | P50747 | 6/20 | 0.47 |
| ▸ | CA12 | O43570 | 7/20 | 0.47 |
| ▸ | CA1 | P00915 | 7/20 | 0.47 |
| ▸ | CA2 | P00918 | 7/20 | 0.47 |
| ▸ | CA9 | Q16790 | 7/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14417216 | 1.00 | TDP1 (0.58) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL17385535 | 1.00 | TDP1 (0.58) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL1549117 | 0.99 | TDP1 (0.57) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL4455260 | 0.92 | TDP1 (0.55) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL18780618 | 0.92 | TDP1 (0.55) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL6033324 | 0.92 | TDP1 (0.55) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL14417100 | 0.92 | TDP1 (0.55) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL12569327 | 0.92 | TDP1 (0.55) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL179912 | 0.92 | TDP1 (0.55) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL20740940 | 0.92 | TDP1 (0.58) | TDP1MEN1ABL1LMNAPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100190257-A1 | Self-Assembly of a Cell-Microparticle Hybrid | THE UNIVERSITY OF IOWA RESEARCH FOUNDATION | 2010-07-29 | — | — | US | claimed |
| EP-4717780-A2 | QUANTITATIVE MASSIVELY PARALLEL PROTEOMICS | Verily Life Sciences LLC (US) | 2026-04-01 | — | — | EP | disclosed |
| EP-3488239-B1 | QUANTITATIVE MASSIVELY PARALLEL PROTEOMICS | VERILY LIFE SCIENCES LLC (US) | 2026-03-25 | — | — | EP | disclosed |
| US-20250199011-A1 | QUANTITATIVE MASSIVELY PARALLEL PROTEOMICS | VERILY LIFE SCIENCES LLC (US) | 2025-06-19 | — | — | US | disclosed |
| CN-119998887-A | Methods and systems for predicting HLA epitopes | 百欧恩泰美国公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-113382750-B | CDCP1 targeted therapy | 贝斯以色列女执事医疗中心 | 2025-05-09 | — | — | CN | disclosed |
| CN-119864090-A | Methods and systems for predicting HLA class II specific epitopes and characterizing CD4+ T cells | 百欧恩泰美国公司 | 2025-04-22 | — | — | CN | disclosed |
| CN-119768425-A | Anti-TL 1A antibodies and methods of use thereof | 辉瑞大药厂 | 2025-04-04 | — | — | CN | disclosed |
| CN-119698427-A | Methods and systems for predicting HLA class II specific epitopes and characterizing CD4+ T cells | 百欧恩泰美国公司 | 2025-03-25 | — | — | CN | disclosed |
| US-12203939-B2 | Quantitative massively parallel proteomics | VERILY LIFE SCIENCES LLC (US) | 2025-01-21 | — | — | US | disclosed |
| WO-2000002575-A1 | PRION PROTEIN AND USES THEREOF | V.I. TECHNOLOGIES, INC. (US) | 2000-01-20 | — | — | WO | disclosed |
| EP-0920623-A1 | BORON NEUTRON CAPTURE THERAPY USING PRE-TARGETING METHODS | Immunomedics, Inc. (US) | 1999-06-09 | — | — | EP | disclosed |
| US-5846741-A | Boron neutron capture therapy using pre-targeting methods | IMMUNOMEDICS, INC. (US) | 1998-12-08 | — | — | US | disclosed |
| US-5821061-A | REACTING A LIGAND IN A SAMPLE WITH A SUBSTANCE BONDED WITH A BACILLUS ALKALINE PHOSPHATASE | TOYO BOSEKI KABUSHIKI KAISHA (JP) | 1998-10-13 | — | — | US | disclosed |
| US-5821095-A | DETECTING A LIGAND IN SAMPLE | TOYO BOSEKI KABUSHIKI KAISHA (JP) | 1998-10-13 | — | — | US | disclosed |
| WO-1998004917-A1 | BORON NEUTRON CAPTURE THERAPY USING PRE-TARGETING METHODS | IMMUNOMEDICS INC. (US) | 1998-02-05 | — | — | WO | disclosed |
| EP-0724015-A2 | Novel alkaline phosphatase, its production and use | TOYO BOSEKI KABUSHIKI KAISHA (JP) | 1996-07-31 | — | — | EP | disclosed |
| EP-0172153-B1 | POLYNUCLEOTIDE HYBRIDIZATION PROBES | SMITHKLINE BECKMAN CORPORATION (US) | 1989-08-09 | — | — | EP | disclosed |
| US-4840892-A | Polynucleotide hybridization probes | SMITHKLINE BECKMAN CORPORATION (US) | 1989-06-20 | — | — | US | disclosed |
| EP-0172153-A1 | Polynucleotide hybridization probes | SMITHKLINE BECKMAN CORPORATION (US) | 1986-02-19 | — | — | EP | disclosed |